Shamik J Parikh insider trades: Humacyte (HUMA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Shamik reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 18, 2026 | HUMA | ↓ Sell | 45,887 | $0.90 | $41K | Direct | May 20, 2026 (2d) |
| Apr 10, 2025 | HUMA | ↑ Buy | 7,500 | $1.55 | $12K | Direct | Apr 14, 2025 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other HUMA insiders
Open-market trades in the last 12 months
About Shamik J Parikh's insider trades
Shamik J Parikh is Chief Medical Officer at Humacyte (HUMA). Since Apr 10, 2025, Shamik has reported 1 open-market purchase worth $12K and 1 sale worth $41K on SEC Form 4. In the last 12 months: 1 sale ($41K).
Their filings also include grants and awards (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HUMA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.